Related Experiment Video
Updated: May 5, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Biomaterial-Based Emergency Intervention for Secondary Spinal Cord Injury
Jincheng Li1,2,3, Qingzheng Zhang1,2,3, Zongtai Liu1,2,3
1Department of Spine Surgery, Center of Orthopedics The First Hospital of Jilin University 1 Xinmin Street Changchun 130061 P. R. China.
Innovative biomaterials offer a promising new avenue for treating acute spinal cord injury (SCI). These advanced materials can help limit inflammation, reduce cell damage, and restore the blood-spinal cord barrier, improving patient outcomes.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Regenerative Medicine
Background:
- Acute spinal cord injury (SCI) requires timely intervention to improve neurological and functional outcomes.
- Current treatments like methylprednisolone (MS) and surgery have limitations and side effects.
- There is a critical need for innovative therapeutic strategies for acute SCI.
Purpose of the Study:
- To review the dynamic changes in SCI tissue during initial phases.
- To examine cutting-edge biomaterial-based interventions for acute SCI.
- To address challenges and opportunities in translating biomaterial research to clinical practice.
Main Methods:
- Literature review of biomaterial applications in acute SCI.
- Analysis of biomaterial strategies targeting inflammation, excitotoxicity, blood-spinal cord barrier restoration, and scar formation.
- Discussion of clinical translation challenges and opportunities.
Main Results:
- Biomaterials can modulate cell behavior and regulate the injured spinal cord microenvironment.
- Specific biomaterial interventions show potential for limiting inflammation, reducing excitotoxicity, restoring the blood-spinal cord barrier, and inhibiting scar formation.
- The review highlights the potential of biomaterials as a promising treatment avenue for acute SCI.
Conclusions:
- Biomaterial-based approaches represent a promising frontier for acute SCI treatment.
- Addressing challenges in clinical translation is crucial for realizing the potential of these innovations.
- Future developments in clinically viable biomaterials are guided by this review.
Related Concept Videos
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

